NL-OMON31540已完成2 期
A pilot study examining the effect of abatacept in ANCA associated vasculitis (AAV) - ABAVAS clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 4
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •Active ANCA-associated vasculitis
排除标准
- •Pregnancy and malignancy, severe life threatening disease, renal insufficiency.
研究者
相似试验
进行中(未招募)
2 期
A Phase II Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients With Undifferentiated Arthritis Who Are at High Risk for the Development of RAndifferentiated Arthritis (UA)Undifferentiated Arthritis (UA)Inflammatory and Immune System - Rheumatoid arthritisACTRN12605000785606Bristol-Myers Squibb Australia50
招募中
不适用
Abatacept Research Outcome as a First-line Biological Agent in the Real WorldRheumatoid ArthritisJPRN-UMIN000004651Division of Rheumatology Department of Internal Medicine, Hyogo College of Medicine100
进行中(未招募)
不适用
Pilot open label clinical trial with Abatacept in Ankylosing Spondylitis - ABATACEPT-AS-01T cell responses have been demonstrated against proteoglycan (an important cartilage protein) in human arthritides including ankylosing spondylitis. We suggest that a chronic, probably T cell mediated, immune response against cartilage is relevant in the pathogenesis of AS.Based on the above described findings about the role of T-cells in ankylosing spondylitis we assume that Abatacept has the potential to be an effective drug for treating ankylosing spondylitis.EUCTR2007-002967-28-DECharité University Medicine30
招募中
不适用
A pilot study investigating the effects of apixaban in patients with chronic disseminated intravascular coagulation (DIC)DICChronic Disseminated Intravascular Coagulation(Chronic DIC)D004211JPRN-jRCTs041180072akayama Takayuki5
已完成
不适用
A pilot study investigating the effects of apixaban in patients with chronic disseminated intravascular coagulation (DIC)Chronic Disseminated Intravascular Coagulation(Chronic DIC)JPRN-UMIN000027469Aichi Medical University Hospital5
